ClinicalTrials.gov
public full text
Public Domain
A Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 2 Diabetes Mellitus
This Phase I clinical trial is a multi-center, single-arm, open-label study aimed at evaluating the safety and efficacy of RGB-5088 islet cell infusion in patients with Type 2 Diabetes Mellitus.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)#407874
- GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes#454144
- Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes#307431
- The Effect Effect of Empagliflozin on Oxidative Stress in Patients With Type 2 Diabetes#907326
- Large-Scale Multi-Omics Enhance Risk Prediction for Type 2 Diabetes#422511
Record · ID 1141125
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive